Takes DVA down -$6.00today on the "proposal."
A once per month O treatment is cheaper vs the AMGEN drugs FWIW.
O = Unmet need
Based upon the above observation, this is not the main reason to re-market O; it is the only reason at this moment in time. expstktrader, thanks for posting this bombastic fact.
Sentiment: Strong Buy